Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Guangzhou Eighth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have been diagnosed as COVID-19 according to The Diagnosis and Treatment Plan for 2019-nCoV(The Fifth Trial Edition); 2. aged between 18 to 80 years old, male or female; 3. the subjects participating the clinical trial are voluntary and sign the informed consent, thoroughly informed the purpose, method, possible reaction.
Exclusion criteria
Exclusion criteria: 1. Patients who are difficult to be administered orally or by nasal feeding, those who are allergic to the test drug and those who are intolerant to the drug; 2. The compliance of medication cannot be guaranteed during the treatment; 3. Patients with severe primary respiratory diseases, or pneumonia caused by other pathogen; 4. Patients with serious diseases, malignant tumors or mental diseases; 5. Pregnant women, urine pregnancy test positive; 6. Participated in other drug trials in the past month; 7. The investigator judged that the patient not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| nucleic acid of nCoV-19;cardiac enzymes;liver and kidney function;lung CT;syndrome;blood count; | — |
Countries
China
Contacts
Public ContactLuping Lin
Guangzhou Eighth People's Hospital
Outcome results
None listed